iNtRON Biotechnology Inc (048530) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of iNtRON Biotechnology Inc stock KRW 2,028, price KRW 2,475, that is 18.1% below the price, quality 44 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
iNtRON Biotechnology Inc
048530 · KQExpensive (fair value 18% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range 2,330 KRW – 25,264 KRW · fair‑value band 1,521 KRW – 2,535 KRW · the 2,475 KRW price screens above the 2,028 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 16, 2026.
Every Wednesday you see whether iNtRON Biotechnology is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
iNtRON Biotechnology, Inc. engages in the development of novel biopharmaceutical drugs in South Korea. It develops bacteriophage and endolysin based drugs through itLysin and IMPA platform. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
Stock analysis
iNtRON Biotechnology Inc (048530) currently trades at 2,475 KRW, while our estimate is 2,028 KRW, 18% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 1,521 KRW (bear) to 2,535 KRW (bull), the price of 2,475 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 44/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Spin-off in 2023: revenue and profit before it include the divested business. Growth is measured afresh from 2023.
iNtRON Biotechnology Inc reported revenue of 5.7B KRW in FY2025 versus 29.3B KRW in FY2021, a compound −33.5%/yr. Reported net income was −9.0B KRW in FY2025.
Key figures
Market cap 76.0B KRW (≈ $57.0M) Micro · P/S ratio 16.3 · EPS (TTM) −290.00 KRW · Dividend yield 4.0% · Return on equity −11.7% · Return on assets (EBIT) −4.1% (5-year average) · Operating margin −120% · Revenue (TTM) 5.7B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).
What moves the price
The share trades about 63% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −6% fair-value upside, at −18%, 048530 screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare iNtRON Biotechnology Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 850 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- Stock screener with 62 metrics
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $957.76 | $1,275 | +33% | vs 048530 |
| Vertex Pharmaceuticals Incorporated VRTX | $534.20 | $592.46 | +11% | vs 048530 |
| Samsung Biologics Co 207940 | 1,414,000 KRW | 1,552,100 KRW | +10% | vs 048530 |
| argenx SE ARGX | $947.52 | $908.40 | −4% | vs 048530 |
| CSL Limited CSL | A$199.38 | A$186.49 | −6% | vs 048530 |
| Moderna, Inc MRNA | $206.80 | $135.64 | −34% | vs 048530 |
| BeOne Medicines AG 6160 | HK$247.40 | HK$152.92 | −38% | vs 048530 |
| Revolution Medicines, Inc RVMD | $162.69 | $88.78 | −45% | vs 048530 |
| Celltrion, Inc 068270 | 213,000 KRW | 74,945 KRW | −65% | vs 048530 |
| Royalty Pharma plc RPRX | $68.68 | $19.01 | −72% | vs 048530 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is iNtRON Biotechnology Inc (048530) overvalued or undervalued?
What is the fair value of 048530?
What is the quality score of 048530?
What is the price target for iNtRON Biotechnology Inc (048530)?
What is the iNtRON Biotechnology Inc stock forecast for 2026?
What is the revenue of iNtRON Biotechnology Inc (048530)?
Does iNtRON Biotechnology Inc pay a dividend?
How much is the dividend of iNtRON Biotechnology Inc (048530)?
What is the intrinsic value of iNtRON Biotechnology Inc (048530)?
Is iNtRON Biotechnology Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 048530?
How much is iNtRON Biotechnology Inc worth?
What do the bullish and bearish scenarios say about 048530?
How solid is the balance sheet of iNtRON Biotechnology Inc (048530)?
How far is 048530 from its 52-week high?
Which stocks are comparable to iNtRON Biotechnology Inc?
Is iNtRON Biotechnology Inc stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of iNtRON Biotechnology Inc (048530)?
What should I pay attention to with iNtRON Biotechnology Inc right now?
Key figures of iNtRON Biotechnology Inc
How large is the market capitalisation of iNtRON Biotechnology Inc (048530)?
What is the P/S ratio of iNtRON Biotechnology Inc (048530)?
What are the earnings per share of iNtRON Biotechnology Inc (048530)?
What is the dividend yield of iNtRON Biotechnology Inc (048530)?
What is the return on equity of iNtRON Biotechnology Inc (048530)?
What is the EBIT return on assets of iNtRON Biotechnology Inc (048530)?
What is the operating margin of iNtRON Biotechnology Inc (048530)?
How fast is revenue growing at iNtRON Biotechnology Inc (048530)?
How fast are earnings growing at iNtRON Biotechnology Inc (048530)?
How much free cash flow does iNtRON Biotechnology Inc (048530) generate?
Watch iNtRON Biotechnology Inc in the live analysis
One click puts iNtRON Biotechnology Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.